B-CELL LYMPHOMA REFRACTORY

This adverse event was reported 89 times

These drugs are most commonly taken by patients reporting B-CELL LYMPHOMA REFRACTORY:

# Drug Count
0 RITUXIMAB 56
1 CYCLOPHOSPHAMIDE 47
2 CYCLOPHOSPHAMIDE FOR INJECTION 47
3 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 47
4 DOXORUBICIN 44
5 ETOPOSIDE 24
6 PREDNISOLONE 24
7 PREDNISOLONE ORAL 24
8 PREDNISOLONE ORAL SOLUTION 24
9 CYTARABINE 23
See all common drugs associated with B-CELL LYMPHOMA REFRACTORY

B-CELL LYMPHOMA REFRACTORY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 EPCORITAMAB-BYSP 12 0.0090
1 IDELALISIB 13 0.0018
2 ELRANATAMAB-BCMM 1 0.0009
3 DOXORUBICIN HYDROCHLORIDE 23 0.0007
4 IFOSFAMIDE FOR INJECTION 14 0.0007
5 BENDAMUSTINE HCL 10 0.0006
6 CARMUSTINE 3 0.0006
7 DOXORUBICIN 44 0.0005
8 THIOTEPA 4 0.0004
9 CYTARABINE 23 0.0004
See all drugs enriched for association with B-CELL LYMPHOMA REFRACTORY